SMTL ID : 6jz0.1

Crystal structure of EGFR kinase domain in complex with compound 78

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.86 Å

Oligo State

monomer

Ligands

1 x CKO: E-4-(dimethylamino)-N-[3-[4-[[(1S)-2-oxidanyl-1-phenyl-ethyl]amino]-6-phenyl-furo[2,3-d]pyrimidin-5-yl]phenyl]but-2-enamide(Non-covalent)

CKO.1: 17 residues within 4Å: Chain A: L.23, V.31, A.48, K.50, M.71, L.93, T.95, Q.96, L.97, M.98, P.99, G.101, C.102, D.105, R.146, L.149, D.160 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.23, A:L.23, A:V.31, A:K.50, A:L.93, A:T.95, A:R.146, A:L.149 Hydrogen bonds: A:M.98, A:C.102, A:D.160 Salt bridges: A:D.105

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lin, S.Y. et al., Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung Cancer. J.Med.Chem. (2019)

Release Date

2019-12-04

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor